These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33761394)
21. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations. Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084 [TBL] [Abstract][Full Text] [Related]
22. Kinetics of viral load and antibody response in relation to COVID-19 severity. Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129 [TBL] [Abstract][Full Text] [Related]
23. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related]
24. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity. McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155 [TBL] [Abstract][Full Text] [Related]
26. Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals. Egia-Mendikute L; Bosch A; Prieto-Fernández E; Lee SY; Jiménez-Lasheras B; García Del Río A; Antoñana-Vildosola A; Bruzzone C; Bizkarguenaga M; Embade N; Gil-Redondo R; Martínez-Chantar ML; López-Hoyos M; Abrescia NGA; Mato JM; Millet Ó; Palazón A Commun Biol; 2021 Apr; 4(1):486. PubMed ID: 33879833 [TBL] [Abstract][Full Text] [Related]
27. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein. Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY mBio; 2020 Oct; 11(5):. PubMed ID: 33082264 [TBL] [Abstract][Full Text] [Related]
28. Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture. Kolesov DE; Sinegubova MV; Safenkova IV; Vorobiev II; Orlova NA PeerJ; 2022; 10():e12751. PubMed ID: 35036106 [TBL] [Abstract][Full Text] [Related]
29. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood. Wang Z; Zheng Z; Hu H; Zhou Q; Liu W; Li X; Liu Z; Wang Y; Ma Y Lab Chip; 2020 Nov; 20(22):4255-4261. PubMed ID: 33064114 [TBL] [Abstract][Full Text] [Related]
30. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381 [TBL] [Abstract][Full Text] [Related]
31. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2. Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841 [TBL] [Abstract][Full Text] [Related]
32. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays. Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042 [TBL] [Abstract][Full Text] [Related]
33. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828 [TBL] [Abstract][Full Text] [Related]
34. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients. Fujigaki H; Inaba M; Osawa M; Moriyama S; Takahashi Y; Suzuki T; Yamase K; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Doi Y; Saito K J Immunol; 2021 May; 206(10):2393-2401. PubMed ID: 33941657 [TBL] [Abstract][Full Text] [Related]
35. Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients. Ihling C; Tänzler D; Hagemann S; Kehlen A; Hüttelmaier S; Arlt C; Sinz A J Proteome Res; 2020 Nov; 19(11):4389-4392. PubMed ID: 32568543 [TBL] [Abstract][Full Text] [Related]
36. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of three fully-automated SARS-CoV-2 antibody assays. Hörber S; Soldo J; Relker L; Jürgens S; Guther J; Peter S; Lehmann R; Peter A Clin Chem Lab Med; 2020 Aug; 58(12):2113-2120. PubMed ID: 32745068 [TBL] [Abstract][Full Text] [Related]
38. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. Demey B; Daher N; François C; Lanoix JP; Duverlie G; Castelain S; Brochot E J Infect; 2020 Aug; 81(2):e6-e10. PubMed ID: 32389784 [TBL] [Abstract][Full Text] [Related]
39. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures. Leuzinger K; Gosert R; Søgaard KK; Naegele K; Bielicki J; Roloff T; Bingisser R; Nickel CH; Khanna N; Sutter ST; Widmer AF; Rentsch K; Pargger H; Siegemund M; Stolz D; Tamm M; Bassetti S; Osthoff M; Battegay M; Egli A; Hirsch HH J Med Virol; 2021 Apr; 93(4):2374-2384. PubMed ID: 33314153 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay. Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]